Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Non-Current Deffered Revenue (2021 - 2025)

Viridian Therapeutics, Inc.\DE has reported Non-Current Deffered Revenue over the past 5 years, most recently at $140000.0 for Q2 2025.

  • Quarterly results put Non-Current Deffered Revenue at $140000.0 for Q2 2025, down 67.29% from a year ago — trailing twelve months through Jun 2025 was $140000.0 (down 67.29% YoY), and the annual figure for FY2024 was $284000.0, down 50.44%.
  • Non-Current Deffered Revenue for Q2 2025 was $140000.0 at Viridian Therapeutics, Inc.\DE, down from $212000.0 in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for VRDN hit a ceiling of $1.1 million in Q4 2021 and a floor of $140000.0 in Q2 2025.
  • Median Non-Current Deffered Revenue over the past 5 years was $645000.0 (2023), compared with a mean of $644600.0.
  • Biggest five-year swings in Non-Current Deffered Revenue: dropped 25.07% in 2022 and later tumbled 67.29% in 2025.
  • Viridian Therapeutics, Inc.\DE's Non-Current Deffered Revenue stood at $1.1 million in 2021, then fell by 25.07% to $861000.0 in 2022, then plummeted by 33.45% to $573000.0 in 2023, then plummeted by 50.44% to $284000.0 in 2024, then plummeted by 50.7% to $140000.0 in 2025.
  • The last three reported values for Non-Current Deffered Revenue were $140000.0 (Q2 2025), $212000.0 (Q1 2025), and $284000.0 (Q4 2024) per Business Quant data.